Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Adicet Bio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 84 | −10 |
| Shares | 37.2M | 40.3K | 35.7M | −1.44M (−3.9%) |
| Value | $90.4M | $98.0K | $48.9M | −$41.4M (−45.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Adicet Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 249,200 | $341.4K | 0.01% |
| Marshall Wace, LLP | 152,508 | $208.9K | 0.00% |
| Acuitas Investments, LLC | 136,779 | $187.4K | 0.11% |
| AQR Capital Management LLC | 75,022 | $102.8K | 0.00% |
| Cubist Systematic Strategies, LLC | 31,745 | $43.5K | 0.00% |
| Marquette Asset Management, LLC | 28,144 | $38.6K | 0.01% |
| SG Americas Securities, LLC | 13,217 | $18.0K | 0.00% |
| Balyasny Asset Management LLC | 12,550 | $17.2K | 0.00% |
| Point72 Middle East FZE | 11,391 | $15.6K | 0.00% |
| Group One Trading, L.P. | 5,487 | $7.52K | 0.00% |
| Comerica Bank | 1,250 | $1.71K | 0.00% |
| Nisa Investment Advisors, LLC | 88 | $121 | 0.00% |
| Glassman Wealth Services | 80 | $110 | 0.00% |
Sold out (23)
Institutions that held Adicet Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Wellington Management Group LLP | 776,305 | $1.89M |
| Candriam Luxembourg S.C.A. | 715,890 | $1.74M |
| Baillie Gifford & Co | 181,626 | $441.4K |
| Trexquant Investment LP | 101,283 | $246.1K |
| UBS Asset Management Americas Inc | 32,279 | $185.9K |
| Jump Financial, LLC | 59,534 | $144.7K |
| Engineers Gate Manager LP | 47,413 | $115.2K |
| Ameriprise Financial Inc | 33,520 | $81.5K |
| Assenagon Asset Management S.A. | 32,960 | $80.1K |
| Y-Intercept (Hong Kong) Ltd | 26,892 | $65.3K |
| Golden State Equity Partners | 23,830 | $57.9K |
| Two Sigma Securities, LLC | 18,207 | $44.2K |
| Schonfeld Strategic Advisors LLC | 17,300 | $42.0K |
| Virtu Financial LLC | 16,097 | $39.0K |
| MetLife Investment Management | 15,993 | $38.9K |
| Centiva Capital, LP | 12,991 | $31.6K |
| Mirae Asset Global Investments Co., Ltd. | 12,804 | $31.1K |
| Voya Investment Management LLC | 12,359 | $30.0K |
| Walleye Capital LLC | 10,002 | $24.3K |
| Public Employees Retirement System of Ohio | 4,070 | $10.0K |
| Metropolitan Life Insurance Co | 1,319 | $3.21K |
| Red Tortoise LLC | 649 | $1.58K |
| Impact Partnership Wealth, LLC | 67 | $163 |
Not filed for Q3 2023 yet (1)
Institutions that held Adicet Bio, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 40,329 | $98.0K |